Centogene N.V.

2.43+0.3700+17.96%Vol 5521Y Perf -80.14%
Jun 24th, 2022 15:52 DELAYED
BID2.03 ASK2.41
Open2.41 Previous Close2.06
Pre-Market- After-Market-
 - -  - -%
Target Price
10.00 
Analyst Rating
Strong Buy 1.00
Potential %
311.52 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     39.21
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     42.70
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.93 
Earnings Rating
Market Cap65.78M 
Earnings Date
29th Jun 2022
Alpha-0.02 Standard Deviation0.20
Beta-1.19 

Today's Price Range

2.412.43

52W Range

1.8311.95

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
5.19%
1 Month
-9.67%
3 Months
-40.88%
6 Months
-53.63%
1 Year
-80.14%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CNTG2.430.370017.96
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.30
0.36
0.84
-54.10
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
14.80
-24.20
-13.00
-24.90
-33.58
RevenueValueIndustryS&P 500US Markets
139.84M
5.17
64.15
50.46
Earnings HistoryEstimateReportedSurprise %
Q04 2021--0.58-
Q03 2021-0.59-1.08-83.05
Q02 2021-0.26-0.45-73.08
Q01 2021-0.15-0.27-80.00
Q04 2020-0.21-
Q03 2020-0.33-0.323.03
Q02 2020-0.51-0.57-11.76
Q01 2020-0.38-0.47-23.68
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date29th Jun 2022
Estimated EPS Next Report-0.56
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume552
Shares Outstanding27.07K
Shares Float13.25M
Trades Count21
Dollar Volume1.30K
Avg. Volume8.51K
Avg. Weekly Volume7.43K
Avg. Monthly Volume8.37K
Avg. Quarterly Volume9.73K

Centogene N.V. (NASDAQ: CNTG) stock closed at 2.43 per share at the end of the most recent trading day (a 17.96% change compared to the prior day closing price) with a volume of 552.0000 shares and market capitalization of 65.78M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 442 people. Centogene N.V. CEO is Arndt Rolfs.

The one-year performance of Centogene N.V. stock is -80.14%, while year-to-date (YTD) performance is -53.54%. CNTG stock has a five-year performance of %. Its 52-week range is between 1.83 and 11.95, which gives CNTG stock a 52-week price range ratio of 5.93%

Centogene N.V. currently has a PE ratio of -1.00, a price-to-book (PB) ratio of 2.19, a price-to-sale (PS) ratio of 0.45, a price to cashflow ratio of 6.50, a PEG ratio of 2.32, a ROA of -38.91%, a ROC of -65.77% and a ROE of -100.77%. The company’s profit margin is -33.58%, its EBITDA margin is -13.00%, and its revenue ttm is $139.84 Million , which makes it $5.17 revenue per share.

Of the last four earnings reports from Centogene N.V., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.56 for the next earnings report. Centogene N.V.’s next earnings report date is 29th Jun 2022.

The consensus rating of Wall Street analysts for Centogene N.V. is Strong Buy (1), with a target price of $10, which is +311.52% compared to the current price. The earnings rating for Centogene N.V. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Centogene N.V. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Centogene N.V. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.02, ATR14 : 0.31, CCI20 : -17.73, Chaikin Money Flow : 0.39, MACD : -0.23, Money Flow Index : 37.62, ROC : -6.90, RSI : 43.65, STOCH (14,3) : 68.97, STOCH RSI : 1.00, UO : 62.95, Williams %R : -31.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Centogene N.V. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Centogene N.V.

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

CEO: Arndt Rolfs

Telephone: +49 38180113400

Address: Am Strande 7, Rostock 18055, , DE

Number of employees: 442

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

Bearish Bullish

53%47%

News

Stocktwits